Clinical Trial Update: Allo-hNHL (FluBuCy) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Allo-hNHL (FluBuCy) in Non-Hodgkin's Lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Allo-hNHL
• FluBuCy

Snippet

Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED